不同抗血小板治疗对急性脑梗死患者血小板活化聚集状态的比较

被引:31
作者
沈明强 [1 ]
程庆璋 [1 ]
石冬敏 [2 ]
机构
[1] 南京医科大学附属苏州医院神经内科
[2] 南京医科大学附属苏州医院检验科
关键词
脑梗死; 血小板活化; CD62P; 血小板聚集率; 抗血小板治疗;
D O I
暂无
中图分类号
R743.3 [急性脑血管疾病(中风)];
学科分类号
摘要
目的:探讨不同抗血小板治疗对脑梗死急性期患者血小板活化及聚集状态的影响。方法:97例脑梗死患者随机入组不同的抗血小板治疗组(阿司匹林治疗组、氯吡格雷治疗组、阿司匹林联合氯吡格雷治疗组),在入院第1天(治疗前)和第10天采用流式细胞仪检测血小板CD62P、比浊法检测花生四烯酸(arachidonic acid,AA)诱导的血小板最大聚集率(MARAA)和二磷酸腺苷(adenosine diphosphate,ADP)诱导的血小板最大聚集率(MARADP)。结果:3组患者入院第1天CD62P、MARAA、MARADP无显著差异,治疗10 d后3组的CD62P、MARAA、MARADP值均下降,与入院第1天的CD62P、MARAA、MARADP值比较,差异有统计学意义。3组脑梗死患者血小板MARADP下降程度组间比较有差异,氯吡咯雷治组MARADP下降明显,阿司匹林联合氯吡格雷治疗组下降更明显。血小板MARAA、血小板CD62P下降程度组间比较无显著差异。结论:阿司匹林、氯吡格雷、阿司匹林联合氯吡格雷3种抗血小板治疗方法均能有效减少脑梗死急性期的血小板活化,降低血小板最大聚集率,提示临床治疗均有效;氯吡格雷和阿司匹林联合治疗更能抑制血小板的聚集,抗血小板疗效更好。
引用
收藏
页码:213 / 216
页数:4
相关论文
共 7 条
[1]  
Clopidogrel plus aspirin versus aspirin alone for reducing embolisation in patients with acute symptomatic cerebral or carotid artery stenosis (CLAIR study): a randomised, open-label, blinded-endpoint trial[J] . Ka Sing Lawrence Wong,Christopher Chen,Jianhui Fu,Hui Meng Chang,Nijasri C Suwanwela,Yining N Huang,Zhao Han,Kay Sin Tan,Disya Ratanakorn,Pavithra Chollate,Yudong Zhao,Angeline Koh,Qing Hao,Hugh S Markus.Lancet Neurology . 2010 (5)
[2]  
Patients With Prior Myocardial Infarction, Stroke, or Symptomatic Peripheral Arterial Disease in the CHARISMA Trial[J] . Deepak L. Bhatt,Marcus D. Flather,Werner Hacke,Peter B. Berger,Henry R. Black,William E. Boden,Patrice Cacoub,Eric A. Cohen,Mark A. Creager,J. Donald Easton,Christian W. Hamm,Graeme J. Hankey,S. Claiborne Johnston,Koon-Hou Mak,Jean-Louis Mas,Gilles Montalescot,Thomas A. Pearson,P. Gabriel Steg,Steven R. Steinhubl,Michael A. Weber,Liz Fabry-Ribaudo,Tingfei Hu,Eric J. Topol,Keit
[3]   Course of platelet activation and platelet-leukocyte interaction in cerebrovascular ischemia [J].
Htun, Patnik ;
Fateh-Moghadam, Suzanne ;
Tomandl, Bernd ;
Handschu, Rene ;
Klinger, Kathrin ;
Stellos, Konstantinos ;
Garlichs, Christoph ;
Daniel, Werner ;
Gawaz, Meinrad .
STROKE, 2006, 37 (09) :2283-2287
[4]   Aspirin resistance [J].
Hankey, GJ ;
Eikelboom, J .
LANCET, 2006, 367 (9510) :606-617
[5]  
Dual Antiplatelet Therapy With Clopidogrel and Aspirin in Symptomatic Carotid Stenosis Evaluated Using Doppler Embolic Signal Detection: The Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) Trial[J] . Hugh S. Markus,Dirk W. Droste,Manfred Kaps,Vincent Larrue,Kennedy R. Lees,Mario Siebler,E Bernd Ringelstein.Circulation . 2005 (17)
[6]  
The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke[J] . The Lancet . 1997 (9065)
[7]  
A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)[J] . The Lancet . 1996 (9038)